BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Forte Research Systems, Inc. Release: OnCore Version 12.0 Delivers Robust Functionality for Supporting Clinical Research Billing Compliance


5/11/2012 9:07:56 AM

MADISON, Wis., May 10, 2012 /PRNewswire/ -- Forte Research Systems, Inc., developer of clinical and translational research software systems, is pleased to announce the newest version of its flagship product, the OnCore clinical research management system. Designed for mid-sized to large academic medical centers, research hospitals, and cancer centers, OnCore Version 12.0 features comprehensive coverage analysis functionality for maintaining billing compliance.

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

OnCore 12.0: The Solution to Billing Compliance Challenges

Inaccurate billing can result in serious consequences for clinical research institutions. Because prevention is the first step to billing compliance, the new Coverage Analysis module offers an array of related features to help institutions manage risk:

  • Qualifying Clinical Trial Checklist provides the ability to store and report information for determining if a protocol meets requirements for insurance reimbursements.
  • Procedure Billing Designations assist with assigning the correct billing codes and documenting the source for the decision.
  • Billing Grid displays procedures and visits with their designations.
  • Multiple Version Management allows for changes as regulations and protocols evolve.
  • Sign-off improves accuracy.

The development of the Coverage Analysis module is a result of the recent partnership with Meade and Roach, LLP, and its subsidiary, Aegis Compliance and Ethics Center, LLP, consulting firms that lent their expertise in the area of research billing compliance throughout the development of the module.

"With the latest enhancement, the OnCore clinical research management system is now the best system available to assist institutions with their billing compliance strategies," said Srini Kalluri, Founder, President, CEO, and Chief Customer Officer at Forte Research Systems.

Largest Release to Date

In its 12-year existence, this is the largest release of the OnCore platform, which required an extensive software engineering effort to perfect the Coverage Analysis module as well as 120 additional enhancements to the system. Among the other top features in the new version:

  • Protocol Submission console for reporting to ClinicalTrials.gov
  • Unified Registries Management application is fully integrated with the Clinical Research and Biospecimen Management applications
  • Biospecimen Management application includes usability enhancements, such as the ability to manage multiple consent forms for individual samples
  • Effort tracking functionality with a variety of filters for generating reports

"The release of OnCore 12.0 is a significant achievement for Forte, as well as the clinical research industry at large. It creates cost and operational efficiencies across the board," Kalluri said. "As the largest release to date, it delivers functionality that is unmatched and further solidifies our position as the leaders in this space."

SOURCE Forte Research Systems, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES